(Q43122470)

English

Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD).

scientific article published on 20 March 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD). (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

0 references

gastroesophageal reflux disease

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Robert M Ward

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Brinda Tammara

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sandra E Sullivan

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Dan L Stewart

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Natalie Rath

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Xu Meng

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Mary K Maguire

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Gail M Comer

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

20 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

555-561

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-010-0811-8

21 January 2018

Single-dose pharmacokinetics of oral and intravenous pantoprazole in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4'-hydroxylation phenotype and genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developmental expression of human hepatic CYP2C9 and CYP2C19.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of pantoprazole in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetics and pharmacogenomics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-dependent pharmacokinetics of lansoprazole in neonates and infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developmental pharmacology--drug disposition, action, and therapy in infants and children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenomics of proton pump inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease and a history of erosive oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20306184

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-010-0811-8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43122470&oldid=2205808645"